2m 2m 2m 2m 2m 2m 2m
Myriad Genetics (MYGN)
NASDAQ
$4.51+$0.45 (+11.08%)
Price as of Oct 02, 2026 6:38 PM EDT- $388.3MMarket Cap
- -46.30%1-Year Change
- Diagnostics & ResearchIndustry
Myriad Genetics (MYGN)
$4.51+$0.45 (+11.08%)
MYGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.06 | ||
Change | -$0.25 (-5.80%) | ||
Open | $4.28 | ||
High | $4.31 | ||
Low | $4.05 | ||
Previous Close | $4.31 | ||
Volume | 1,657,900 | ||
30-Day Average Volume | 2,093,617 | ||
1-Week Change | -1.93% | ||
1-Month Change | 27.67% | ||
1-Year Change | -46.30% | ||
3-Year Change | -74.69% | ||
5-Year Change | -87.27% | ||
Fundamentals | |||
Shares Outstanding | 95.6M | ||
Total Assets | $638.9M | ||
Market Cap | $388.3M | ||
Enterprise Value | $393.8M | ||
Period: QTR TTM FY | |||
Revenue | $190.7M | ||
Net Income | -$43.2M | ||
Free Cash Flow | -$8.3M | ||
EBIT | -$42.6M | ||
EBITDA | -$30.1M | ||
Net Working Capital | $158.3M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 03/26/2009 | ||
Earnings & Revenue